Five cases are reported of superior mesenteric vein thrombosis occurring in women taking oral contraceptives.
Introduction
Women taking oral contraceptives have an increased risk of developing deep vein thrombosis and pulmonary embolism (Inman & Vessey 1968) . The incidence of superficial vein thrombosis is increased (Royal College of General Practitioners, 1967) , and idiopathic cerebral vein thrombosis may occur in these patients (Atkinson, Fairburn & Heathfield, 1970) . It might be expected therefore that the visceral venous system would also be liable to thrombosis in patients taking oral contraceptives.
Idiopathic superior mesenteric vein thrombosis is an uncommon but well documented condition (Berry & Bougas, 1950; Naitove & Weismann, 1965) that occurs most often in middle-aged or elderly patients. However, four cases have already been reported in young women taking oral contraceptives (Reed & Coon, 1963; Civetta & Kolodny, 1970; Hurwitz et al., 1970) (Warren & Eberhard, 1935) and these authors noted a number of cases where no cause, local or general, could be found. This 'idiopathic' superior mesenteric vein thrombosis has since been discussed in detail (Naitove & Weismann, 1965 , Trinkle et al., 1969 . Its relationship to portal vein thrombosis is unclear, and it has been suggested both that portal vein thrombosis may spread distally to involve the mesenteric veins (Thompson & Sherlock 1964) , and also that segmental mesenteric vein thrombosis may spread proximally to involve the portal vein (Mavor, 1966) .
Idiopathic superior mesenteric vein thrombosis occurs in all age groups but is most common in the middle-aged and elderly. Men are more often M. B. Rose affected than women. A past history of venous thrombosis occurring elsewhere in the body is common (Naitove & Weismann, 1965; North & Wollenman, 1952) (Reed & Coon, 1963; Civetta & Kolodny, 1970; Hurwitz et al., 1970) , and five more are here reported. The disease is similar in presentation and clinical course to the 'idiopathic' form, apart from occurring in younger women. The mortality in these cases has been high (56%) and apparently not affected by the use of anticoagulants, although the numbers are small (Table 2 ). In six cases the contraceptive pill taken was known, and three were of the 'high oestrogen' type containing 100 tzg or more of oestrogen preparation. This type (Inman et al., 1970) .
It has been pointed out by Doll & Vessey (1970) that the evaluation of rare side-effects of oral contraceptives is difficult. It (Brennan Clarke & Macbeth, 1968; Welin & Persson, 1968) . Ischaemic colitis has also been described in such patients (Kilpatrick et al., 1968; Ward & Stevenson, 1968; Hurwitz et al., 1970; Cotton & Lea Thomas, 1971) but the aetiology of this condition is uncertain. All these conditions are rare, and comparison of the incidence in patients taking oral contraceptives with others is difficult.
At present therefore, it is impossible to prove a causal relationship between oral contraceptives and superior mesenteric vein thrombosis. It is suggested, however, that an accurate record of all drugs taken by a patient is essential, and that the possibility of a visceral venous thrombosis should be considered in any woman who presents with abdominal pain while taking oral contraceptives.
